Sasaki Ryoki, Kojima Sho, Onishi Hideaki
Institute for Human Movement and Medical Sciences, Niigata University of Health and Welfare, Niigata, Japan.
Discipline of Physiology, Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia.
Front Hum Neurosci. 2021 Sep 28;15:742373. doi: 10.3389/fnhum.2021.742373. eCollection 2021.
Techniques of non-invasive brain stimulation (NIBS) of the human primary motor cortex (M1) are widely used in basic and clinical research to induce neural plasticity. The induction of neural plasticity in the M1 may improve motor performance ability in healthy individuals and patients with motor deficit caused by brain disorders. However, several recent studies revealed that various NIBS techniques yield high interindividual variability in the response, and that the brain-derived neurotrophic factor (BDNF) genotype (i.e., Val/Val and Met carrier types) may be a factor contributing to this variability. Here, we conducted a systematic review of all published studies that investigated the effects of the BDNF genotype on various forms of NIBS techniques applied to the human M1. The motor-evoked potential (MEP) amplitudes elicited by single-pulse transcranial magnetic stimulation (TMS), which can evaluate M1 excitability, were investigated as the main outcome. A total of 1,827 articles were identified, of which 17 (facilitatory NIBS protocol, 27 data) and 10 (inhibitory NIBS protocol, 14 data) were included in this review. More than two-thirds of the data (70.4-78.6%) on both NIBS protocols did not show a significant genotype effect of NIBS on MEP changes. Conversely, most of the remaining data revealed that the Val/Val type is likely to yield a greater MEP response after NIBS than the Met carrier type in both NIBS protocols (21.4-25.9%). Finally, to aid future investigation, we discuss the potential effect of the BDNF genotype based on mechanisms and methodological issues.
人类初级运动皮层(M1)的无创脑刺激(NIBS)技术在基础研究和临床研究中被广泛用于诱导神经可塑性。M1中神经可塑性的诱导可能会改善健康个体以及患有脑部疾病导致运动功能障碍患者的运动表现能力。然而,最近的几项研究表明,各种NIBS技术在反应上存在高度的个体间差异,并且脑源性神经营养因子(BDNF)基因型(即Val/Val和Met携带者类型)可能是导致这种差异的一个因素。在此,我们对所有已发表的研究进行了系统综述,这些研究调查了BDNF基因型对应用于人类M1的各种形式NIBS技术的影响。将能够评估M1兴奋性的单脉冲经颅磁刺激(TMS)诱发的运动诱发电位(MEP)幅度作为主要观察指标进行研究。共检索到1827篇文章,其中17篇(促进性NIBS方案,27个数据)和10篇(抑制性NIBS方案,14个数据)纳入本综述。两种NIBS方案中超过三分之二的数据(70.4 - 78.6%)未显示NIBS对MEP变化有显著的基因型效应。相反,其余大多数数据表明,在两种NIBS方案中,Val/Val型在NIBS后产生的MEP反应可能比Met携带者型更大(21.4 - 25.9%)。最后,为了有助于未来的研究,我们基于机制和方法学问题讨论了BDNF基因型的潜在影响。